Its using two suicide inhibitors (6-OXO and formestane) as AI's and synephrine, nor-synephrine and tyramine for glucose uptake/adipose reduction in peripheral tissue. Looks like they are trying to deliver them using a localized carrier. Looks interesting as a localized fat burner, but I would have preferred to see them use ATD for gyno reduction (in lou of 6-OXO or formestane).